ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Identification of ALG3 as a potential prognostic biomarker in lung adenocarcinoma

Yuan, Yinjiao; Xie, BaoCheng; Guo, Dongbo; Liu, Caixiang; Jiang, Guanming; Lai, Guowei; Zhang, Yu; Hu, Xiarong; Wu, Zhiming; Zheng, Ruinian*; Huang, Linxuan*南方医科大学; 海南大学; 中山大学; 6; 1; 东莞市人民医院
Heliyon2023-7DOI: 10.1016/j.heliyon.2023.e18065
6阅读
引用收藏
分享

摘要

Background: The abnormal expression of Alpha-1,3-mannosyltransferase (ALG3) has been implicated in tumor promotion. However, the clinical significance of ALG3 in Lung Adenocarcinoma (LUAD) remains poorly understood. Therefore, we aimed to assess the prognostic value of ALG3 and its association with immune infiltrates in LUAD. Methods: The transcriptional expression profiles of ALG3 were obtained from the Cancer Genome Atlas (TCGA), comparing lung adenocarcinoma tissue with normal tissues. To determine the prognostic significance of AGL3, Kaplan-Meier plotter, and Cox regression analysis were employed. Logistic regression was utilized to analyze the association between ALG3 expression and clinical characteristics. Additionally, a receiver operating characteristic (ROC) curve and a nomogram were constructed. To explore the underlying mechanisms, the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis and gene set enrichment analysis (GSEA) was conducted. The relationship between AGL3A mRNA expression and immune infiltrates was investigated using the tumor immune estimation resource (TIMER) and tumorimmune system interaction database (TISIDB). Furthermore, an in vitro experiment was performed to assess the impact of ALG3 mRNA on lung cancer stemness abilities and examine key signaling pathway proteins. Results: Our results revealed the ALG3 mRNA and protein expression in patients with LUAD was much higher than that in adjacent normal tissues. High expression of ALG3 was significantly associated with N stage (N0, HR = 1.98, P = 0.002), pathological stage (stage I, HR = 2.09, P = 0.003), and the number of pack years (<40, HR = 2.58, P = 0.001). Kaplan-Meier survival analysis showed that high expression of ALG3 was associated with poor overall survival (P < 0.001), disease-free survival (P < 0.001), and progression-free interval (P = 0.007). Through multivariate analysis, it was determined that elevated ALG3 expression independently impacted overall survival (HR = 1.325, P = 0.04). The Tumor Immune Estimation Resource discovered a link between ALG3 expression and tumor-infiltrating immune cells in LUAD. Additionally, ROC analysis proved that ALG3 is a reliable diagnostic marker for LUAD (AUC:0.923). Functional pathways analysis identified that ALG3 is negatively correlated with FAT4. We performed qRTPCR to assess that knockdown ALG3 expression significantly upregulated FAT4 expression. Spheroid assay and flow cytometry analysis results showed that downregulated of ALG3 inhibited H1975 cell line stemness. Western blot analysis revealed that decreased ALG3 inhibited the YAP/ TAZ signal pathway. Conclusion: High expression of ALG3 is strongly associated with poor prognosis and immune infiltrates in LUAD.

学科与关键词

关键词
Lung adenocarcinomaALG3Prognostic biomarkerImmune infiltration
相关
加载中…
  • Expression of ALG3 in Hepatocellular Carcinoma and Its Clinical Implication
    Zhao, Zhen; Zheng, Zehao; Huang, Jianfeng; Wang, Jianxi; Peng, Tianyi; Lin, Ye*; Jian, Zhixiang*Frontiers in Molecular Biosciences, 2022, 9: 816102.被引 2
  • B3GNT3 as a prognostic biomarker and correlation with immune cell infiltration in lung adenocarcinoma
    Wu, Yuanzhou; Luo, Jianmin; Li, Hui; Huang, Yang; Zhu, Yaru; Chen, Qunqing*Annals of Translational Medicine, 2022, 10(6).被引 5
  • TTYH3 is a Prognostic Biomarker and Associates with Immune Cell Infiltrations of Lung Adenocarcinoma
    Xu, Jian; Chen, Jiming; Duan, Honglu; Zhang, Dandan; Li, Yilu; Xu, Xiaoni; Li, Xiaoli*INTERNATIONAL JOURNAL OF MORPHOLOGY, 2023, 41(1): 118-133.
查看全部 →

发表信息

论文状态
公开发表
期刊
Heliyon
发表日期
2023-07
卷期
第 9 卷, 第 7 期
页码
e18065
DOI
10.1016/j.heliyon.2023.e18065
成果收录
SCIE
资助标注
Guangdong Basic and Applied Basic Research Foundation, China [2021B1515140031, 2020A1515110029]; Dongguan Science and Technology of Social Development Program, China [2019507163147, 20211800905222, 2020507163160]; Postdoctoral Foundation of Dongguan People 's Hospital, China [K202009]; Natural Science Foundation of Guangdong Province natural science fund of Guangdong, China [2021A1515010156, 2022A1515140134]; National Natural Science Foundation of China [32100627]

作者

  • Y

    Yuan, Yinjiao (第一作者)

    dongguan peoples hosp · southern med univ · 1

  • X

    Xie, BaoCheng

    southern med univ

查看全部 11 位作者收起作者
  • G

    Guo, Dongbo

    hainan univ

  • L

    Liu, Caixiang

    dongguan peoples hosp · southern med univ

  • J

    Jiang, Guanming

    dongguan peoples hosp · southern med univ

  • L

    Lai, Guowei

    southern med univ

  • Z

    Zhang, Yu

    6 · sun yat sen univ

  • H

    Hu, Xiarong

    southern med univ

  • W

    Wu, Zhiming

    southern med univ

  • Z

    Zheng, Ruinian (通讯)

    dongguan peoples hosp · southern med univ

  • H

    Huang, Linxuan (通讯)

    dongguan peoples hosp · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417